Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Glecirasib (KRAS G12C inhibitor 36) is a potent inhibitor targeting the oncogenic KRAS G12C mutation, a key signaling molecule within the Ras protein family that is crucial for cell growth and development. This compound shows promise for the investigation of cancers mediated by KRAS G12C mutations[1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,670.00 | |
50 mg | 8-10 weeks | $ 2,180.00 | |
100 mg | 8-10 weeks | $ 2,800.00 |
Description | Glecirasib (KRAS G12C inhibitor 36) is a potent inhibitor targeting the oncogenic KRAS G12C mutation, a key signaling molecule within the Ras protein family that is crucial for cell growth and development. This compound shows promise for the investigation of cancers mediated by KRAS G12C mutations[1]. |
Synonyms | JAB-21822, KRAS G12C inhibitor 36 |
Molecular Weight | 640.03 |
Formula | C31H26ClF4N7O2 |
CAS No. | 2657613-87-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Glecirasib 2657613-87-9 GPCR/G Protein MAPK Ras JAB-21822 KRAS G12C inhibitor 36 inhibitor inhibit